Book an appointment

Oncology · 2026

Breast cancer treatment,
MDT pathway, NMPA targeted therapy.

Multi-disciplinary team review, surgery from $6,500, NMPA-approved targeted therapy (trastuzumab deruxtecan, palbociclib, olaparib), and reconstructive surgery at China's leading breast cancer centres.

Get a written quote Top breast cancer centres

MDT

Standard pathway

Surgery + medical + radiation + reconstructive in one centre

Standard at Class A

NMPA

Targeted therapy approved

T-DXd, palbociclib, ribociclib, olaparib, talazoparib

NMPA approvals

$6,500–13,500

Lumpectomy + SLN

vs $25,000–60,000 in the US

Partner clinic quotes 2024

Bilingual

Pathology + report

ER/PR/HER2/Ki67 + NGS where indicated

Service standard

Reconstructive

Same-trip option

Implant, DIEP, latissimus flap at flagship centres

Centre programs

Trial access

ADC + immunotherapy

Active pipeline of ADC and IO trials

NMPA registry

Tiers & pricing

Six tiers, transparent pricing.

Step 1

Diagnostic workup + biopsy

Mammogram + US + MRI as needed, core biopsy with full IHC and HER2 ISH if equivocal.

$1,200–2,500

BCS

Lumpectomy + sentinel LN

Breast-conserving surgery with SLN biopsy. Same-day or 1-night discharge.

$6,500–11,000

Surgical

Mastectomy ± reconstruction

Modified radical, skin-sparing or nipple-sparing mastectomy. Implant or DIEP reconstruction.

$8,500–22,000

Medical onc

Adjuvant chemotherapy

Standard of care regimens (AC-T, TC, etc.) at NMPA-listed pricing 30–50% below US.

$6,500–18,000

Targeted

Targeted / HER2 / endocrine

Trastuzumab biosimilar, T-DM1, T-DXd, pertuzumab, CDK4/6, PARP inhibitors per indication.

$280–1,800 / month

Adjuvant

Radiation therapy

Whole-breast or partial breast irradiation; hypofractionation standard. IMRT / VMAT.

$5,500–11,000 / course

Top hospitals

Six centres
open to international patients.

Shanghai

Fudan University Shanghai Cancer Center 复旦大学附属肿瘤医院

China's leading breast cancer centre · MDT · large adjuvant volume · trial site

Beijing

Cancer Hospital of CAMS 中国医学科学院肿瘤医院

National cancer reference · breast surgery + radiation + medical onc · proton therapy

Guangzhou

Sun Yat-sen University Cancer Center 中山大学肿瘤防治中心

Class A · breast MDT · regional reference · trial site

Tianjin

Tianjin Medical University Cancer Hospital 天津医科大学肿瘤医院

Class A specialty · large breast cancer service · reconstructive program

Beijing

Beijing Cancer Hospital 北京大学肿瘤医院

Class A · academic breast oncology · trial leadership

Multi-city

United Family Cancer Center 和睦家肿瘤

Private oncology · English-first · partner with Class A teaching for surgery / radiation

Cost comparison

China vs US vs UK,
real pricing.

China
United States
United Kingdom
Lumpectomy + SLN biopsy
$6,500–$11,000
$25,000–$60,000
£10,000–£18,000
Mastectomy + reconstruction
$8,500–$22,000
$45,000–$100,000
£18,000–£35,000
AC-T chemo (8 cycles)
$6,500–$12,000
$25,000–$60,000
£8,000–£18,000
1 yr trastuzumab biosimilar
$8,500–$18,000
$60,000–$130,000
£18,000–£40,000
Whole-breast radiation
$5,500–$9,500
$25,000–$60,000
£8,000–£18,000

Sources: NCCN-aligned pricing, CMS HCUP 2023, NHS specialist commissioning 2024, partner-hospital itemized quotes 2024–2025. Indicative; oncology pricing is highly case-specific.

FAQ

Frequently asked questions.

Why China for breast cancer treatment?
Chinese flagship cancer centres run high-volume MDT breast cancer programs with the same drugs and devices used worldwide. NMPA-approved targeted and immunotherapy access is wide and listed at 30–50% below US prices: trastuzumab biosimilars, T-DM1 (Kadcyla), T-DXd (Enhertu), pertuzumab, palbociclib, ribociclib, abemaciclib, olaparib, talazoparib, atezolizumab, pembrolizumab. Active trial pipelines include ADCs (sacituzumab tirumotecan, multiple HER2-low ADCs) and combinations.
What is included in the MDT pathway?
Multi-disciplinary review at top centres includes: breast surgical oncology, medical oncology, radiation oncology, breast pathology, breast radiology, plastic / reconstructive surgery, genetic counseling (BRCA), and palliative care where indicated. Output is a written treatment plan signed by all attending specialists, with rationale, expected timeline, and home-team handover instructions. Bilingual final report is standard.
What about reconstruction?
Options at flagship centres: implant-based (tissue expander → permanent implant or single-stage direct-to-implant); DIEP / TRAM autologous flap; latissimus dorsi flap; oncoplastic lumpectomy with local flap. Indicative pricing: implant reconstruction $5,500–$12,000; DIEP $12,000–$22,000. Timing — immediate (same operation as mastectomy) or delayed. Discuss with both breast surgeon and plastic surgeon before deciding.
What is the cost comparison vs the US?
Indicative all-in international-patient pricing for full standard-of-care: stage I–II breast cancer with lumpectomy + radiation + endocrine therapy $35,000–$70,000 in China vs $150,000–$300,000+ in the US; HER2+ stage II with neoadjuvant targeted + surgery + adjuvant + 1 year HER2 therapy $80,000–$140,000 in China vs $300,000–$600,000+ in the US. Quotes are case-specific and depend on regimen, length of stay and trial enrolment.
Is there access to clinical trials?
Yes — Chinese breast cancer trial pipeline is among the world's most active. Active categories: novel ADC (Trop-2, HER3, HER2-low); next-gen CDK inhibitors; AKT inhibitors; novel SERDs (oral degraders); IO combinations. Eligibility screening against NMPA registry is offered as a $450–$950 service; see [Clinical Trials in China](/clinical-trials-china).
What about hereditary breast cancer testing?
BRCA1/2, PALB2, ATM, CHEK2 and full hereditary breast/ovarian cancer panel testing at Class A centres: $650–$1,400. Genetic counseling included. Positive findings inform surgical decision (consider bilateral mastectomy), surveillance plan for unaffected breast and ovaries, and family cascade testing recommendations. See our genetic-screening page.

Related guides

Cancer Treatment Hub

All cancer pathways in China including proton, CAR-T and second opinion.

Read the guide

Second Opinion

Independent breast oncology second opinion from $250.

Read the guide

Clinical Trials

Breast cancer trial screening and protocol matching.

Read the guide

Women's Health

Comprehensive women's health workup including breast and pelvic.

Read the guide

BRCA Testing

Hereditary breast cancer genetic counseling and testing.

Read the guide

Records Translation

Bilingual translation of pathology and treatment plans.

Read the guide

Send your records
for an MDT review.

Upload your pathology, imaging, IHC/FISH, and recent labs. We coordinate an MDT review at a partner cancer centre with a written treatment plan and itemized quote within 7 business days.

Request a quote Cancer treatment overview

This page is for general information only and does not constitute medical advice. Cancer treatment decisions are made by the treating oncology team based on case-specific factors. We do not guarantee outcomes.